All Resources

Access to Medicine • February 24, 2026

Increasing Access to Innovative Medicines

Written Submission for the Pre-Budget Consultations in Advance of the 2026-2027 New Brunswick Budget…

Learn more | View

Access to Medicine • January 30, 2026

Increasing Access to Innovative Medicines

Written Submission for the Pre-Budget Consultations in Advance of the 2026 Ontario Budget January 2026…

Learn more | View

Access to Medicine • January 15, 2026

Increasing Access to Innovative Medicines

Written Submission for the Pre-Budget Consultations in Advance of the 2026 Alberta Budget…

Learn more | View

Access to Medicine • December 15, 2025

Increasing Access to Innovative Medicines

Written Submission for the Pre-Budget Consultations in Advance of the 2026 Nova Scotia Budget…

Learn more | View

November 03, 2025

Submission to the Government of Canada’s Consultation on the Review of the Canada – United States -Mexico Agreement

Learn more | View

Patented Medicine Prices Review Board (PMPRB) • July 22, 2025

Reflections on a Potential Federal Drug Formulary: Medicines Industry Response to CDA Consultation

Learn more | View

Access to Medicine • May 06, 2025

Canadian Drug Access Pathway

Learn more | View

March 19, 2025

IMC Response to the PMPRB’s March 2025 Guidelines Consultation

Learn more | View

Access to Medicine • March 10, 2025

Increasing Access to Innovative Medicines

Written Submission for the Pre-Budget Consultations in Advance of the Upcoming Federal Budget…

Learn more | View

Antimicrobial Resistance (AMR) • January 27, 2025

Letter to the Standing Committee on Health

Learn more | View

Patented Medicine Prices Review Board (PMPRB) • September 11, 2024

IMC Response to the PMPRB’s 2024 Discussion Guide on the Board’s Guidelines

Learn more | View

Patented Medicine Prices Review Board (PMPRB) • January 04, 2024

IMC Response to the PMPRB’s 2023 Scoping Paper for the Consultations on the Board’s Guidelines

Learn more | View